Stock Analiz

Haoxi Health Technology Ltd HAO

Advertising · IPO 2024 · data as of November 13, 2026

$2.08Market cap $1M
Open the interactive analysis →

Haoxi Health Technology Ltd (HAO) is a consumer discretionary company listed in the US with a market value of about $1M. In fiscal year 2026 it had revenue of $55M and net income of -$10M, a net margin of -17.4%.

Its overall Stock Analiz score is 1.2 out of 5 (weak). The strongest part is future growth (3/5); the weakest is track record (0/5).

Key numbers: a 5-year average ROIC of 2%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 8045% above the current price.

About Haoxi Health Technology

Haoxi Health Technology is listed in the US and classified in advertising, IPO year 2024. Revenue went from $16M in 2022 to $55M in 2026, growth of about 35.7% a year. It was profitable in 4 of the last 5 years in our data. It spends 0% of revenue on research and development.

Score: 1.2 / 5

Value1/5
Future growth3/5
Track record0/5
Financial health2/5
Shareholder returns0/5

Checks passed

  • Price below intrinsic value (DCF, moderate assumptions)
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity
  • Liabilities below 60% of assets

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • PEG below 1.5
  • Profit margin improving
  • 3-year free cash flow growth above 10% a year
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.0
P/B0.1
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield—
Shareholder yield0.0%
Intrinsic value vs. price+8045%

Growth and quality

Revenue growth (1 yr)67.1%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)0.4%
ROIC (5-yr avg.)2.1%
Profitable years (of last 10)4
Years paying a dividend—

Financials, last 5 years

Fiscal year20262025202420232022
Revenue$55M$33M$49M$28M$16M
Net income-$10M$4M$1M$969752$244587
Free cash flow——-$802943-$917632-$684059
EPS (diluted)$-14.96$6.08$2.03$1.52$0.38
Net margin-17.4%11.8%2.7%3.4%1.5%
ROIC-42.1%-10.3%10.3%50.4%—

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Is Haoxi Health Technology stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 8045% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does Haoxi Health Technology pay a dividend?

Not currently.

Is Haoxi Health Technology a good stock to buy?

We do not give buy or sell advice. Haoxi Health Technology scores 1.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.